Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
68.05
Change Change %
2.15 3.26%

Updated:27 Oct, 2021, 16:13 PM IST

BSE
68.00
Change Change %
2.10 3.19%

Updated:27 Oct, 2021, 16:00 PM IST

Marksans Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 16.65 11.95 39.39%
Adjustments for Expenses & Provisions 19.99 12.50 59.91%
Adjustments for Liabilities & Assets -8.79 -22.39 60.75%
Cash Flow from operating activities 23.17 -13.62 270.09%
Cash Flow from investing activities -7.52 -7.69 2.15%
Cash Flow from financing activities -17.50 20.75 -184.36%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -1.85 -0.57 -226.89%
Opening Cash & Cash Equivalents 2.56 3.13 -18.08%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 0.71 2.56 -72.15%
Top
Listen to the latest songs, only on JioSaavn.com